Epizyme Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EPIZYME INC, and when can generic versions of EPIZYME INC drugs launch?
EPIZYME INC has one approved drug.
There are twenty-two US patents protecting EPIZYME INC drugs.
There are three hundred and thirty-five patent family members on EPIZYME INC drugs in thirty-nine countries.
Summary for Epizyme Inc
| International Patents: | 335 |
| US Patents: | 22 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Epizyme Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,369,155 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 11,052,093 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,420,775 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,855,275 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,821,113 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,549,931 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,155,002 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Epizyme Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2906538 | ⤷ Subscribe |
| Denmark | 3628670 | ⤷ Subscribe |
| Australia | 2024201171 | ⤷ Subscribe |
| Portugal | 3220916 | ⤷ Subscribe |
| South Korea | 20200066380 | ⤷ Subscribe |
| China | 112168967 | ⤷ Subscribe |
| Canada | 2832843 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
